NCT02682121View on ClinicalTrials.gov

Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Prediabetes
Interventions
DRUG

Metformin

Metformin 850 mg twice daily

DRUG

Placebo

Placebo twice daily

Trial Locations (1)

84112

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT02682121 - Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo | Biotech Hunter | Biotech Hunter